News

As Laura Loomer wields a terrifying amount of power, other far-right influencers are accusing her of being a “plant.” ...
Jeffrey Epstein’s convicted accomplice revealed something interesting about her communication with the Trump administration.
I do not work for Big Pharma. I work in support of President Trump on the outside of the administration,’ Loomer tells The ...
As Laura Loomer wields a terrifying amount of power, other far-right influencers are accusing her of being a “plant.” ...
The number of biopharma professionals let go has increased year over year for three straight months. In July, nearly 8,000 ...
The FDA is allowing Sarepta to resume shipments of Elevidys (delandistrogene moxeparvovec) to ambulatory patients with Duchenne muscular dystrophy.
After Loomer targeted surgeon general nominee and Kennedy ally Casey Means, Means’s brother, Calley, suggested that Loomer’s ...
The cost of high-end, breakthrough medications traumatizes patients and their families. According to USAfacts, “national ...
CAMBRIDGE, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment of ...
Sarepta and Capricor learned of key regulatory decisions from the media and investors, and Duchenne muscular dystrophy ...
Vinay Prasad's interim replacement has concerns about same drug that drove him out. NIH director says employee critics ...
Two major health agencies are facing leadership reshuffles, with the resignations of the FDA’s Vinay Prasad and NICE’s Dr Sam Roberts.